Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Account Payables (2016 - 2025)

PAVmed has reported Change in Account Payables over the past 5 years, most recently at $339000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 78.42% year-over-year to $339000.0; the TTM value through Dec 2025 reached $24000.0, up 103.23%, while the annual FY2025 figure was $24000.0, 140.68% up from the prior year.
  • Change in Account Payables for Q4 2025 was $339000.0 at PAVmed, up from -$47000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $3.9 million in Q1 2022 and troughed at -$2.9 million in Q2 2022.
  • A 5-year average of -$96052.6 and a median of -$97000.0 in 2023 define the central range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 466.54% in 2022 and fell as far as 266.57% in 2022.
  • Year by year, Change in Account Payables stood at -$2.7 million in 2021, then skyrocketed by 108.73% to $239000.0 in 2022, then tumbled by 259.0% to -$380000.0 in 2023, then soared by 150.0% to $190000.0 in 2024, then surged by 78.42% to $339000.0 in 2025.
  • Business Quant data shows Change in Account Payables for PAVM at $339000.0 in Q4 2025, -$47000.0 in Q3 2025, and $18000.0 in Q2 2025.